Nanotechnology Databases

Comprehensive databases for nanomaterials, events, products,
companies, research labs, degree programs and publications

 

Nanobiotechnology and Nanomedicine Companies

 

Showing results 1 - 25 of 100 for companies in category Analysis:

 
Accium offers laboratory services based on its Accelerator Mass Spectrometry platform used to detect 14C/12C ratios which provided 1,000 times more sensitivity than the most sensitive method available today such as LC/MS. It is now possible to trace biomolecule delivery in healthy subjects with low attomole sensitivity.
Develops in-vitro models of cell and tissue systems. They simulate the transport of substances and formulations across biological barriers, from which conclusions regarding permeability and absorption can be drawn.
The company has developed and produced superparamagnetic nanoparticles for in vitro diagnostic and life sciences.
Digital microfluidics is a lab-on-a-chip approach based on direct, programmable micromanipulation of nanoliter volume droplets using electrical fields. Digital microfluidics enables complex, multi-step liquid handling protocols to be flexibly, scalably, and cost effectively implemented.
Develops and to markets a novel, automated chip-based technology for mass spectrometry users with the microfluidics chip containing an array of nanoelectrospray nozzles.
Affymetrix GeneChip microarray technology is the industry-standard tool for analyzing complex genetic information. The GeneChip solution consists of oligonucleotide arrays, instruments to process and analyze the arrays, and software tools to manage and mine the data.
Agave BioSystems harnesses the extreme specificity and sensitivity of biological systems to build unique and useful nanoscale engineered devices and systems for diagnostic and analyical applications.
Akonni Biosystems is a molecular diagnostics (MDx) company that develops, manufactures, and markets integrated molecular diagnostic systems.
A nano-biotechnology company with a nanoscale drug discovery technique for systematically scanning 'molecular diversity space'. The company has also developed technology for molecular manufacturing.
ANT has strategic focus in the research, development and manufacture of real time and near real time diagnostics to detect biochemical discharges in manufacturing and environmental situations. The company currently concentrates on the following biochemical detection systems: Enzymes, Dioxins, Estrogen Steroids.
AnaSpec, Inc. is a leading provider of integrated proteomics solutions for worldwide life science research. With a vision for innovation through synergy, AnaSpec offers expertise in three primary technologies: peptides, detection reagents, and combinatorial chemistry. AnaSpec carries a broad product line of biochemicals and reagents for basic research, high-throughput screening and drug discovery. In conjunction, AnaSpec provides premier custom services including peptide synthesis, antibody production, and assay development.
ANP's mission is to develop cutting-edge technology platforms at the nano/bio interface and apply them in market sectors such as diagnostics/biodetection, protein/drug discovery, therapeutics, chem/bio defense, and homeland security.
Arrogene is developing a new generation of diagnostic and therapeutic drugs based utilizing a family of new nano biopolymers.
Attana AB develops and sells biosensors for analysis of biomolecular interactions. Attana's biosensors can be used to determine specificity, kinetics and affinity, amongst other binding characteristics of biomolecules and macrostructures of varying species such as cells, antibodies, proteins, viruses and bacteria.
Axela's automated platforms for multiplexed DNA, RNA and protein analysis are designed for rapid biomarker testing in clinical research and diagnostics.
Manufactures gold colloid particles for use in immuno conjugates.
Beckman Coulter, Inc. is a leading manufacturer of biomedical testing instrument systems, tests and supplies that simplify and automate laboratory processes. Spanning the biomedical testing continuum – from pioneering medical research and clinical trials to laboratory diagnostics and point-of-care testing – Beckman Coulter's 200,000 installed systems provide essential biomedical information to enhance health care around the world.
The company produces BioPixels™, semiconductor-based, nanocrystalline fluorescent markers for cell and intracellular detection and analysis.
As a manufacturer of nanoliter dispensing equipment, BioDot has had extensive experience with the development BioDot is the leading supplier of system tools for the research, development and commercialization of diagnostic tests. As a manufacturer of nanoliter dispensing equipment, BioDot has had extensive experience with the development of manufacturing processes for the protein array industry.
Developer of ultra-miniaturized nanoarray technologies. Molecular analysis systems are capable of providing nanometer scale, single molecule resolution. Applications in proteomics, diagnostics, and therapeutics.
The company develops clinical diagnostics systems including molecular biology-based assays.
Combining the latest in nanotechnology and biotechnology, the company's Irys System with its nanovhannels allows to visualize the whole genome, capturing extremely long molecules at high resolution.
A bionanotech designer and maker of nanostructured chips, devices and systems for fast, comprehensive, and low-cost analysis of native state genomic, epigenomic and proteomic information with sensitivity at the single cell / single molecule level.
BioPAL provides products and methods to measure in vivo organ function and to track compounds-of-interest in in vivo systems. Products developed for neutron activation technology include nanocolloids for labeling, tracking and quantifying cells in in vivo models.
Through its diagnostic program, Biophage is developing a biosensor using an innovative nanotechnology. These nanosensors are based on impedance spectroscopy, an enabling technology that can detect and quantify microbial pathogens in real-time. The unique nanosensors will be built from various proprietary technologies already developed by Biophage (biocapture molecule: phages and antibodies) and by the Biotechnology Research Institute-NRC (signal generation and detection).
 
 
left arrowBack to Nanotechnology Links Directory